This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Ravija Singh: Innovator in Antibody Formulations
Introduction
Ravija Singh is a prominent inventor based in Fremont, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. Her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Ravija Singh holds a patent for her invention titled "Anti-IL-36R antibody formulations." This patent relates to anti-interleukin-36 receptor (anti-IL-36R1) antibody formulations designed for administration to a subject. This innovative formulation has the potential to impact therapeutic approaches in various medical conditions.
Career Highlights
Ravija Singh is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role involves research and development in the field of antibody therapies, where she applies her expertise to create effective treatment options.
Collaborations
Throughout her career, Ravija has collaborated with notable colleagues, including Derrick Spencer Katayama and Ingo Michael Presser. These collaborations have enhanced her research and contributed to the advancement of her projects.
Conclusion
Ravija Singh's innovative work in antibody formulations exemplifies her commitment to advancing medical science. Her contributions are paving the way for new therapeutic options that could benefit many patients in need.